Rising awareness of personalized medicine is contributing to the expansion of the South and Central America Cancer Targeted Therapy Market and supporting more individualized treatment strategies. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of 11.6%...